HLUN-A:CPH
H Lundbeck A/S Class A
45,05 DKK
arrow_upward
+0,33%(+0,15) 1K
16-okt, 17:00:00 (GMT+2) · DKK
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoHLUN-A tikeri uchun statistika yaratilmoqda...
Ochish
45,00 DKK
Yuqori
45,60 DKK
Past
44,90 DKK
Bozor kapitali
47,05 mlrd
Oʻrtacha hajm
100,68 ming
Hajmi
0,00
52 haftalik eng yuqori
45,60 DKK
52 haftalik eng past
31,40 DKK
Muomaladagi aksiyalar
199,15 mln
Xodimlar soni
5 ming
Ochish
45,00 DKK
Yuqori
45,60 DKK
Past
44,90 DKK
Bozor kapitali
47,05 mlrd
Oʻrtacha hajm
100,68 ming
Hajmi
0,00
52 haftalik eng yuqori
45,60 DKK
52 haftalik eng past
31,40 DKK
Muomaladagi aksiyalar
199,15 mln
Xodimlar soni
5 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo! Finance Canada
·
6 daqiqa oldin
NTHI,VITL,SRAD,HERZ,EFOR,TRIN,FFIN,NXRT,AVBC,CULP,BLCO,BBSI,VSNT,VIRC,GRNT,SSP,GAIA,CSPI,AFCG,AWRE,APCX,KLTR,AUBN,BETR | Stock Prices | Quote Comparison
The Motley Fool
·
13 daqiqa oldin
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Simply Wall Street
·
56 daqiqa oldin
Is INmune Bio (NASDAQ:INMB) In A Good Position To Deliver On Growth Plans?
Profil
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
H Lundbeck A/S Class A haqida